Skip to main content
BMC Neurology logoLink to BMC Neurology
. 2021 Sep 24;21:368. doi: 10.1186/s12883-021-02403-5

Combination of structural MRI, functional MRI and brain PET-CT provide more diagnostic and prognostic value in patients of cerebellar ataxia associated with anti-Tr/DNER: a case report

Sisi Shen 1,#, Wenyu Liu 1,#, Ming Zhou 2, Ruiyi Yang 2, Jinmei Li 1,, Dong Zhou 1,
PMCID: PMC8461997  PMID: 34560837

Abstract

Background

Brain magnetic resonance imaging (MRI) rarely reveals structural changes in patients with suspected anti-Tr/DNER encephalitis and thus provides very limited information. Here, we combined structural MRI, functional MRI, and positron emission tomography-computed tomography (PET-CT) findings to characterize this rare disorder in a patient.

Case presentation

A 43-year-old woman presented with progressive cerebellar ataxia, memory impairment, anxiety, and depression. Anti-Tr antibodies were detected in both her serum (1:10) and cerebrospinal fluid (1:10). A diagnosis of anti-Tr-positive autoimmune cerebellar ataxia was established. The patient’s symptoms were worse, but her brain MRI was normal. Meanwhile, voxel-based morphometry analysis showed bilateral reduced cerebellar volume, especially in the posterior lobe and uvula of the cerebellum and the middle of the left temporal lobe compared with 6 sex- and age-matched healthy subjects (6 females, 43 ± 2 years; p < 0.05). Using seed-based functional connectivity analysis, decreased connectivity between the posterior cingulate cortex/precuneus and left frontal lobe compared to the control group (p < 0.05) was detected. PET-CT revealed bilateral hypometabolism in the cerebellum and relative hypermetabolism in the cerebellar vermis and bilateral frontal lobe, but no malignant changes.

Conclusions

A combination of structural MRI, functional MRI, and brain PET-CT has higher diagnostic and prognostic value than conventional MRI in patients with suspected anti-Tr/DNER encephalitis.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12883-021-02403-5.

Background

Cerebellar ataxia associated with anti-Tr/DNER (Delta/Notch-like epidermal growth factor-related receptor) autoantibodies is a rare autoimmune disease characterized by progressively acute or sub-acute severe cerebellar ataxia that eventually disables affected patients [15]. Progression of this disorder is often irreversible, which is consistent with the total loss of cerebellar Purkinje cells observed at autopsy [4]. A full understanding and early diagnosis of this disease is crucial, as prompt treatment can prevent disability [6]. The major feature of this disorder is severe cerebellar ataxia, which highlights abnormalities of the cerebellum. However, patients often present with other symptoms, such as extensor plantar response [7], retrobulbar optic neuropathy [7], encephalopathy [4], sensory neuropathy and limbic encephalitis [4], which is indicative of the involvement of areas outside the cerebellum. Detecting areas affected in this rare disorder by morphological examination is important, because exploring the associations between affected areas and clinical manifestations may help clarify the pathophysiological mechanisms and predict prognosis of this disease.

However, initial evaluations using conventional brain magnetic resonance imaging (MRI) rarely reveals structural changes [1, 5]. Even when changes are present, they are often subtle or nonspecific, resulting in MRIs providing very limited information. Voxel-based morphometry (VBM), which is an MRI processing technique that can detect regional morphological changes throughout the brain, resting state functional MRI (fMRI), which is an emerging functional imaging technique that analyzes spontaneous fluctuations in the blood oxygen level-dependent (BOLD) signal to assess functional connectivity (FC) of remote brain areas, and positron emission tomography-computed tomography (PET-CT) have been successfully used to detect structural and functional changes in various nervous system diseases. Here, we hypothesize that multimodal imaging analyses may also reveal structural and functional changes in the brains of patients with anti-Tr/DNER cerebellar ataxia, increasing the pathophysiological and prognostic value of these assessments. In this study, we combined MRI with VBM, FC, and PET-CT to assess a patient and characterize this rare disorder.

Case presentation

A 43-year-old woman presented with dizziness for 3 months along with worsening dysarthria and ataxia for 1 month. Apart from severe cerebellar ataxia, she also complained of depression for 2 months, as well as memory loss and blurred vision for 2 weeks. Physical examination showed speech dysarthria and bilateral horizontal gaze-evoked nystagmus that was more obviously towards the right. Finger-nose and heel-shin tests revealed severe ataxia, which had rendered the patient bedridden. Laboratory findings, including complete blood cell count and biochemical, metabolic, infectious, immunologic, and serologic tests, were normal. Cerebrospinal fluid and conventional brain MRI examination were unremarkable. The patient had a Mini Mental Status Examination (MMSE) score of 27 and a Montreal Cognitive Assessment (MOCA) total score of 21. She experienced impairment of short-term memory (2/5), visuospatial functions (1/5), and attention (4/6). The Hamilton Anxiety Scale (HAMA) and Hamilton Depression Scale (HAMA) revealed mild anxiety (15) and moderate depression (23). Anti-Tr antibodies were detected in both her serum (1:10) and cerebrospinal fluid (1:10). Due to the strong association of anti-Tr with malignancy, whole-body contrast computed tomography, ultrasounds of thyroid, breast, and reproductive organs, and bone marrow aspiration were performed for further investigation. However, no malignant changes were found. A diagnosis of anti-Tr positive autoimmune cerebellar ataxia in the absence of malignancy was established and the patient received immune therapy successively. Patient therapy consisted of steroid pulse therapy (5 days of 1 g/d intravenous methylprednisolone sodium succinate, and then 60 mg/d prednisone) followed by intravenous immunoglobulin (0.4 g/kg per day for 5 days). After intravenous therapy, the patient was discharged from the hospital and underwent rehabilitation at home with continual prednisone treatment that was decreased weekly by 5 mg. Patient symptoms and treatment were shown in Fig. 1A.

Fig. 1.

Fig. 1

Clinical and imaging features of cerebellar ataxia patient associated with anti-Tr/DNER antibodies. A: The symptoms and treatment measures of the patient; B: VBM analysis showed reduced cerebellar volume bilaterally, especially in the posterior lobe and uvula of cerebellum, and the middle of the left temporal lobe compared with controls; C: The seed-based FC investigation showed lower connectivity between posterior cingulate cortex (PCC)/precuneus and left frontal lobe than that of the control group; D: Brain PET-CT showed obvious decreased fluorodeoxyglucose (FGD) uptake in bilateral cerebellum; E: whole-body PET-CT showed no malignant changes were found

Upon her re-admission 1 month later, the patient’s major complaint was worsening of the ataxia and an increased cognitive-emotional deficit. In recent years, increasing evidence for a role for the cerebellum in emotion and cognition has emerged [812] and the patient was identified as having cerebellar cognitive affective syndrome [13]. The default mode network (DMN) has become the primary and most popular target of resting state networks and is thought to be involved in advanced cognitive functions and emotion [1416]. Recent fMRI studies have linked activity to cognition and explored how FC is altered in several diseases. The disrupted connectivity within the DMN and remote interregional connectivity related to hubs of DMN have been widely reported in terms of changes related to cognitive deficits. The posterior cingulate cortex (PCC)/precuneus is a pivotal hub in the DMN [17] and also has been linked to many cognitive-emotional disorders [15, 16, 18]. Therefore, to further assess the structural and functional abnormalities and reveal the mechanism underlying the cognitive-emotional deficit in this patient, VBM, PCC and cerebellum seed-based FC analysis were performed at the whole-brain level in addition to PET-CT. Acquisition sequences of sMRI and fMRI were seen in supplementary materials.

VBM analysis showed bilateral reductions in cerebellar volume, especially in the posterior lobe and uvula of cerebellum and the middle of the left temporal lobe in comparison with 6 sex- and age-matched healthy subjects (6 females, 43 ± 2 years; p < 0.05; Fig. 1B). Seed-based FC assessment identified reduced connectivity between the PCC/precuneus and left frontal lobe compared to the control group (p < 0.05; Fig. 1C). PET-CT revealed bilateral hypometabolism of the cerebellum and relative hypermetabolism of the cerebellar vermis and bilateral frontal lobe (Fig. 1D), but no malignant changes (Fig. 1E). An intravenous of injection of cyclophosphamide was offered at 0.4 g/d for 3 days, followed by Tacrolimus as a long-term immunosuppressive treatment. Unfortunately, the patient failed to improve.

At one-year follow up, the patient repeated the whole-body contrast PET-CT, ultrasounds of thyroid, breasts, and reproductive organs, and bone marrow biopsy with no evidence of malignancy. At this time, her symptoms have not improved.

Discussion and conclusions

We report a confirmed case of anti-Tr positive autoimmune cerebellar ataxia with no signs of malignancy at 1 year follow up. Studies show that 84.6–94.7 % of patients with this disease also present with Hodgkin’s lymphoma with a median time between diagnosis of cerebellar ataxia and Hodgkin’s lymphoma or any other tumor type being 3.5 months (ranging from 0 to 24 months) [2, 4, 5]. No tumors have been found in our patient, suggesting that, in a few instances, the origin of the anti-Tr antibodies is not a tumor but another unknown cause, such as a para-infectious origin [1]. It is important to note that the follow-up period may have been too short to confidently rule out malignancy for this patient.

Our study illustrates multimodality imaging can be more sensitive than conventional MRI in detection of brain damage and may aid in explaining clinic-radiological discrepancies. In this patient, bilateral reductions in volume and obvious hypometabolism in the cerebellum were observed, which is consistent with her irreversible severe cerebellar ataxia. A postpartum study of patients with anti-Tr/DNER cerebellar ataxia found strong anatomical evidence in the form of the total loss of cerebellar Purkinje cells [4]. Of note, relative hypermetabolism in the cerebellar vermis and bilateral frontal lobe was also observed in our patient, which might be indicative of underlying inflammation [19]. Regions with abnormal hypometabolism and hypermetabolism as identified by PET-CT are also observed in autoimmune encephalitis [19] and paraneoplastic cerebellar degeneration [20]. Reduced middle of the left temporal lobe volume and lower connectivity between the PCC and left frontal lobe can explain patient’s cognitive-emotional deficit. These structures are all parts of the DMN, which has been linked to cognitive-emotional processing [17]. Grimm and Simone et al. investigated neural activity in the DMN during different emotional tasks in healthy subjects and patients with major depressive disorder in an event-related fMRI design. They found decreased negative BOLD responses in the PCC and ventromedial prefrontal cortex in patients with major depressive disorder that correlated with depression severity and feelings of hopelessness [15]. The PCC and ventromedial prefrontal cortex have also been shown to be involved in short-term memory, visuospatial functions, and attention using a number of fMRI studies [14, 18, 21]. Involvement of extra-cerebellar regions is also supported by neuroanatomy studies. In rats, anti-Tr antibody immunoreactivity was not confined to the Purkinje cells of the cerebellum but was also observed in the plexiform layers of the hippocampus and neocortex [22, 23].

The cerebellum may also play a role in cognitive-emotional deficits in patient. Anatomically, there are extensive anatomical connections between the cerebellum and associated paralimbic areas, such as the temporoparietal junction, lateral temporal cortex, PCC, inferior frontal gyrus, amygdala, and insula [24, 25]. Most of these are part of the DMN described above and involved in processing of cognition and emotions. Additional insight was derived from VBM studies [9, 26]. For example, Olivito et al. assessed the relationship between cerebellar gray matter (GM) atrophy and neuropsychological scores in patients with spinocerebellar ataxia 2 using VBM and found GM loss in the cognitive posterior lobules (VI, Crus I, Crus II, VIIB, and IX) that correlated with visuospatial, verbal memory, and executive tasks [26]. Further evidence has been provided by RS-fMRI studies that showed altered FC between cerebellar and cerebrum regions, which are known to be related to cognition and emotion, in patients with spinocerebellar ataxia 2, depression, and Alzheimer’s disease [9, 2730]. In our patient, VBM analysis revealed atrophy in both the DMN structure and cerebellum. FC analysis demonstrated decreased connectivity in the DMN. Based on the studies mentioned above, we suggest the cognitive-emotional deficits in our patient were caused by disfunction of the cerebellum and DMN.

Notably, the reduced left frontal lobe-precuneus connectivity seen in our patient is nonspecific. Recent work has shown impairment of motor and cognitive cerebellar-neocortical networks in chronic ataxias, such as spinocerebellar ataxia 17 [31]. Similarly, other groups have recently outlined deficits in cerebellar-neocortical networks and cerebellar-striatal connectivity in patients with multiple system atrophy (MSA) [32] and overactivity in the olivary-cerebellar-thalamic network in patients with an essential tremor [33]. Here, we give the first insight into cerebellar-neocortical network functionality in anti-Tr positive autoimmune cerebellar ataxia. However, caution is needed when interpreting our results as this study consisted of only one patient. Our findings should be evaluated using larger cohort studies.

In conclusion, we report a confirmed case of anti-Tr positive autoimmune cerebellar ataxia with no tumor signs at 1 year follow up. A combination of structural MRI, functional MRI, and brain PET-CT has diagnostic and prognostic value in patients with suspected anti-Tr/DNER encephalitis. Disfunction of the cerebellum and DMN may contribute to the cognitive-emotional deficits seen in this disorder.

Supplementary Information

Additional file 1. (13.6KB, docx)

Acknowledgements

Not applicable.

Abbreviations

DNER

Delta/Notch-like epidermal growth factor-related receptor

MRI

Magnetic resonance imaging

VBM

Voxel-based morphometry

RS-fMRI

Resting state functional magnetic resonance imaging

BOLD

Blood oxygen level-dependent

FC

Functional connectivity

PET-CT

Positron emission tomography-computed tomography

CSF

Cerebrospinal fluid

MMSE

Mini Mental Status Examination

MOCA

Montreal Cognitive Assessment

HAMA

Hamilton Anxiety Scale

HAMD

Hamilton Depression Scale

DMN

Default mode network

PCC

Posterior cingulate cortex

GM

Gray matter

MSA

Multiple system atrophy

Authors’ contributions

Data acquisition: SSS, WYL, MZ and RYY; data interpretation: SSS, WYL; writing—original draft preparation: SSS; writing—review and editing: WYL, MZ and RYY; design and conceptualization: JML, DZ. All authors have read and approved this manuscript.

Funding

None.

Availability of data and materials

All data used in this study are available from the corresponding author on reasonable request.

Declarations

Ethics approval and consent to participate

This study was approved by the ethics committee of West China Hospital.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Competing interests

None disclosed.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Sisi Shen and Wenyu Liu have contributed equally to this paper and should be considered co-first authors.

Contributor Information

Jinmei Li, Email: jinmeili-neuro@qq.com.

Dong Zhou, Email: zhoudong66@yahoo.de.

References

  • 1.de Graaff E, Maat P, Hulsenboom E, van den Berg R, van den Bent M, Demmers J, et al. Identification of delta/notch-like epidermal growth factor-related receptor as the Tr antigen in paraneoplastic cerebellar degeneration. Ann Neurol. 2012;71(6):815–24. doi: 10.1002/ana.23550. [DOI] [PubMed] [Google Scholar]
  • 2.Probst C, Komorowski L, de Graaff E, van Coevorden-Hameete M, Rogemond V, Honnorat J, et al. Standardized test for anti-Tr/DNER in patients with paraneoplastic cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm. 2015;2(2):e68. doi: 10.1212/nxi.0000000000000068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Briani C, Vitaliani R, Grisold W, Honnorat J, Graus F, Antoine JC, et al. Spectrum of paraneoplastic disease associated with lymphoma. Neurology. 2011;76:8. doi: 10.1212/WNL.0b013e31820d62eb. [DOI] [PubMed] [Google Scholar]
  • 4.Bernal F, Shams’ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology. 2003;60(2):230–4. doi: 10.1212/01.WNL.0000041495.87539.98. [DOI] [PubMed] [Google Scholar]
  • 5.Jarius S, Wildemann B. ’Medusa head ataxia’: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation. 2015;12:168. doi: 10.1186/s12974-015-0358-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Razzak A, Shields M, Allsup D. Autoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma. Leuk Lymphoma. 2007;48(7):1456–8. doi: 10.1080/10428190701387047. [DOI] [PubMed] [Google Scholar]
  • 7.Graus F, Dalmau J, Valldeoriola F, Ferrer I, Rene R, Marin C, et al. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin’s disease. J Neuroimmunol. 1997;74(1–2):55–61. doi: 10.1016/s0165-5728(96)00205-6. [DOI] [PubMed] [Google Scholar]
  • 8.Clausi S, Lupo M, Olivito G, Siciliano L, Contento MP, Aloise F, et al. Depression disorder in patients with cerebellar damage: awareness of the mood state. J Affect Disord. 2019;245:386–93. doi: 10.1016/j.jad.2018.11.029. [DOI] [PubMed] [Google Scholar]
  • 9.Lupo M, Olivito G, Iacobacci C, Clausi S, Romano S, Masciullo M, et al. The cerebellar topography of attention sub-components in spinocerebellar ataxia type 2. Cortex. 2018;108:35–49. doi: 10.1016/j.cortex.2018.07.011. [DOI] [PubMed] [Google Scholar]
  • 10.Lupo M, Olivito G, Siciliano L, Masciullo M, Molinari M, Cercignani M, et al. Evidence of Cerebellar Involvement in the Onset of a Manic State. Front Neurol. 2018;9:774. doi: 10.3389/fneur.2018.00774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Clausi S, Iacobacci C, Lupo M, Olivito G, Molinari M, Leggio M. The role of the cerebellum in unconscious and conscious processing of emotions: a review. Appl Sci. 2017;7(5):521. doi: 10.3390/app7050521. [DOI] [Google Scholar]
  • 12.Tedesco AM, Chiricozzi FR, Clausi S, Lupo M, Molinari M, Leggio MG. The cerebellar cognitive profile. Brain. 2011;134(12):3672–86. doi: 10.1093/brain/awr266. [DOI] [PubMed] [Google Scholar]
  • 13.Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(Pt 4):561–79. doi: 10.1093/brain/121.4.561. [DOI] [PubMed] [Google Scholar]
  • 14.Geday J, Gjedde A. Attention, emotion, and deactivation of default activity in inferior medial prefrontal cortex. Brain Cogn. 2009;69(2):344–52. doi: 10.1016/j.bandc.2008.08.009. [DOI] [PubMed] [Google Scholar]
  • 15.Grimm S, Boesiger P, Beck J, Schuepbach D, Bermpohl F, Walter M, et al. Altered Negative BOLD responses in the default-mode network during emotion processing in depressed subjects. Neuropsychopharmacology. 2009;34(4):932–43. doi: 10.1038/npp.2008.81. [DOI] [PubMed] [Google Scholar]
  • 16.Shim G, Oh JS, Jung WH, Jang JH, Choi C-H, Kim E, et al. Altered resting-state connectivity in subjects at ultra-high risk for psychosis: an fMRI study. #N/A. 2010;6(1):58. 10.1186/1744-9081-6-58. [DOI] [PMC free article] [PubMed]
  • 17.Sreenivas S, Boehm SG, Linden DEJ. Emotional faces and the default mode network. Neurosci Lett. 2012;506(2):229–34. doi: 10.1016/j.neulet.2011.11.012. [DOI] [PubMed] [Google Scholar]
  • 18.Zarifkar P, Kim J, La C, Zhang K, YorkWilliams S, Levine TF, et al. Cognitive impairment in Parkinson’s disease is associated with default mode network subsystem connectivity and cerebrospinal fluid Aβ. Parkinsonism Relat Disord. 2021;83:71–8. doi: 10.1016/j.parkreldis.2021.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Probasco JC, Solnes L, Nalluri A, Cohen J, Jones KM, Zan E, et al. Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2017;4(4):e352. doi: 10.1212/nxi.0000000000000352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Abdulaziz ATA, Yu XQ, Zhang L, Jiang XY, Zhou D, Li JM. Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: case report. Med (Baltim) 2018;97(24):e10717. doi: 10.1097/md.0000000000010717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Lehmann M, Madison CM, Ghosh PM, Seeley WW, Mormino E, Greicius MD, et al. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2013;110(28):11606–11. doi: 10.1073/pnas.1221536110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Eiraku M, Hirata Y, Takeshima H, Hirano T, Kengaku M. Delta/Notch-like Epidermal Growth Factor (EGF)-related Receptor, a Novel EGF-like Repeat-containing Protein Targeted to Dendrites of Developing and Adult Central Nervous System Neurons*. J Biol Chem. 2002;277(28):25400–7. doi: 10.1074/jbc.M110793200. [DOI] [PubMed] [Google Scholar]
  • 23.Graus F, Gultekin SH, Ferrer I, Reiriz J, Alberch J, Dalmau J. Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin’s disease in the rat nervous system. Acta Neuropathol. 1998;96(1):1–7. doi: 10.1007/s004010050853. [DOI] [PubMed] [Google Scholar]
  • 24.Mar RA. The neural bases of social cognition and story comprehension. Annu Rev Psychol. 2011;62:103–34. doi: 10.1146/annurev-psych-120709-145406. [DOI] [PubMed] [Google Scholar]
  • 25.Calder AJ, Lawrence AD, Young AW. Neuropsychology of fear and loathing. #N/A. 2001;2(5):352–63. 10.1038/35072584. [DOI] [PubMed]
  • 26.Olivito G, Lupo M, Iacobacci C, Clausi S, Romano S, Masciullo M, et al. Structural cerebellar correlates of cognitive functions in spinocerebellar ataxia type 2. J Neurol. 2018;265(3):597–606. doi: 10.1007/s00415-018-8738-6. [DOI] [PubMed] [Google Scholar]
  • 27.Wei Q, Ji Y, Bai T, Zu M, Guo Y, Mo Y, et al. Enhanced cerebro-cerebellar functional connectivity reverses cognitive impairment following electroconvulsive therapy in major depressive disorder. Brain Imaging Behav. 2021;15(2):798–806. doi: 10.1007/s11682-020-00290-x. [DOI] [PubMed] [Google Scholar]
  • 28.Guo W, Liu F, Xue Z, Gao K, Liu Z, Xiao C, et al. Abnormal resting-state cerebellar-cerebral functional connectivity in treatment-resistant depression and treatment sensitive depression. Prog Neuropsychopharmacol Biol Psychiatry. 2013;44:51–7. doi: 10.1016/j.pnpbp.2013.01.010. [DOI] [PubMed] [Google Scholar]
  • 29.Pagen LHG, van de Ven VG, Gronenschild E, Priovoulos N, Verhey FRJ, Jacobs HIL. Contributions of Cerebro-Cerebellar Default Mode Connectivity Patterns to Memory Performance in Mild Cognitive Impairment. #N/A. 2020;75(2):633–47. 10.3233/jad-191127. [DOI] [PMC free article] [PubMed]
  • 30.Olivito G, Serra L, Marra C, Di Domenico C, Caltagirone C, Toniolo S, et al. Cerebellar dentate nucleus functional connectivity with cerebral cortex in Alzheimer’s disease and memory: a seed-based approach. Neurobiol Aging. 2020;89:32–40. doi: 10.1016/j.neurobiolaging.2019.10.026. [DOI] [PubMed] [Google Scholar]
  • 31.Reetz K, Dogan I, Rolfs A, Binkofski F, Schulz JB, Laird AR, et al. Investigating function and connectivity of morphometric findings–exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17) NeuroImage. 2012;62(3):1354–66. doi: 10.1016/j.neuroimage.2012.05.058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Baggio HC, Abos A, Segura B, Campabadal A, Uribe C, Giraldo DM, et al. Cerebellar resting-state functional connectivity in Parkinson’s disease and multiple system atrophy: Characterization of abnormalities and potential for differential diagnosis at the single-patient level. Neuroimage Clin. 2019;22:101720. doi: 10.1016/j.nicl.2019.101720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Fang W, Lv F, Luo T, Cheng O, Liao W, Sheng K, et al. Abnormal regional homogeneity in patients with essential tremor revealed by resting-state functional MRI. PLoS One. 2013;8(7):e69199. doi: 10.1371/journal.pone.0069199. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Additional file 1. (13.6KB, docx)

Data Availability Statement

All data used in this study are available from the corresponding author on reasonable request.


Articles from BMC Neurology are provided here courtesy of BMC

RESOURCES